Krämer, Bernhard K., Del Castillo, Domingo, Margreiter, Raimund, Sperschneider, Heide, Olbricht, Christoph J., Ortuno, Joaquin, ...
BACKGROUND: The European tacrolimus versus ciclosporin A microemulsion (CsA-ME) renal transplantation study showed that tacrolimus was significantly more effective in preventing acute rejection and...
Krämer, Bernhard K., Del Castillo, Domingo, Margreiter, Raimund, Sperschneider, Heide, Olbricht, Christoph J., Ortuño, Joaquín, ...
Background. The European tacrolimus versus ciclosporin A microemulsion (CsA-ME) renal transplantation study showed that tacrolimus was significantly more effective in preventing acute rejection and...
Montagnino, Giuseppe, Sandrini, Silvio, Iorio, Beniamino, Schena, Francesco Paolo, Carmellini, Mario, Rigotti, Paolo, ...
Background. Everolimus and cyclosporine exhibit synergistic immunosuppressive activity when given in combination. In this randomized trial, we explored whether the use of everolimus associated with...
Van Hooff, Johannes P, Squifflet, Jean-Paul, Salmela, Kaija, Rigotti, Paolo, Jindal, Rahul M, ...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunosuppressant like tacrolimus or cyclosporine with adjunctive agents like corticosteroids,...
Use of a BJAB-Derived Cell Line for Isolation of Human Herpesvirus 8
Gasperini, Paola, Barbierato, Massimo, Martinelli, Canio, Rigotti, Paolo, Marchini, Francesco, Masserizzi, Giulia, ...
Establishment of latently infected cell lines from primary effusion lymphomas (PEL) presently is the most efficient system for the propagation of clinical strains of human herpesvirus 8 (HHV-8) in...
Use of a BJAB-Derived Cell Line for Isolation of Human Herpesvirus 8
Gasperini, Paola, Barbierato, Massimo, Martinelli, Canio, Rigotti, Paolo, Marchini, Francesco, Masserizzi, Giulia, ...
Establishment of latently infected cell lines from primary effusion lymphomas (PEL) presently is the most efficient system for the propagation of clinical strains of human herpesvirus 8 (HHV-8) in...